Latest Articles

Publication Date
All News Scientific
Chance test spotted symptom-less pre-cancer in 25-year-old's colon - MSN

Chance test spotted symptom-less pre-cancer in 25-year-old's colon MSN

Published: April 18, 2025, 9:09 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Rhian Butlin’s unnecessary hysterectomy and cancer that changed her life forever - MSN

Rhian Butlin’s unnecessary hysterectomy and cancer that changed her life forever MSN

Published: April 18, 2025, 1:02 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery - Cureus

Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery Cureus

Published: April 17, 2025, 11:08 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer - Nature

The role of IGF2BP3/SPOP/c-Myc loop in paclitaxel resistance of endometrial cancer Nature

Published: April 17, 2025, 12:18 p.m.
Read Full Article
Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer - Physician's Weekly

Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer Physician's Weekly

Published: April 17, 2025, 10:41 a.m.
Read Full Article
Role of Lymphadenectomy in the Management of Early-Stage Endometrial Cancer - Cureus

Role of Lymphadenectomy in the Management of Early-Stage Endometrial Cancer Cureus

Published: April 17, 2025, 6:27 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!